Versant Capital Management, Inc Alkermes Plc. Transaction History
Versant Capital Management, Inc
- $454 Million
- Q4 2024
A detailed history of Versant Capital Management, Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 716 shares of ALKS stock, worth $25,260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
716
Previous 221
223.98%
Holding current value
$25,260
Previous $6,000
233.33%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ALKS
# of Institutions
376Shares Held
173MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$653 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$432 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$311 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$267 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.79B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...